CN117143900A - Bacillus coagulans engineering bacterium with ambr gene knocked out as well as preparation method and application thereof - Google Patents
Bacillus coagulans engineering bacterium with ambr gene knocked out as well as preparation method and application thereof Download PDFInfo
- Publication number
- CN117143900A CN117143900A CN202311128270.6A CN202311128270A CN117143900A CN 117143900 A CN117143900 A CN 117143900A CN 202311128270 A CN202311128270 A CN 202311128270A CN 117143900 A CN117143900 A CN 117143900A
- Authority
- CN
- China
- Prior art keywords
- amtr
- gene
- bacitracin
- bacillus licheniformis
- knockout
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 47
- 241000894006 Bacteria Species 0.000 title claims abstract description 25
- 238000002360 preparation method Methods 0.000 title claims abstract description 7
- 241000193749 Bacillus coagulans Species 0.000 title 1
- 229940054340 bacillus coagulans Drugs 0.000 title 1
- CLKOFPXJLQSYAH-ABRJDSQDSA-N bacitracin A Chemical compound C1SC([C@@H](N)[C@@H](C)CC)=N[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1C(=O)N[C@H](CCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2N=CNC=2)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC1 CLKOFPXJLQSYAH-ABRJDSQDSA-N 0.000 claims abstract description 51
- 108010001478 Bacitracin Proteins 0.000 claims abstract description 50
- 229960003071 bacitracin Drugs 0.000 claims abstract description 50
- 229930184125 bacitracin Natural products 0.000 claims abstract description 50
- 241000194108 Bacillus licheniformis Species 0.000 claims abstract description 39
- 238000010353 genetic engineering Methods 0.000 claims abstract description 8
- 239000002773 nucleotide Substances 0.000 claims abstract description 4
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 4
- 239000012634 fragment Substances 0.000 claims description 27
- 238000000855 fermentation Methods 0.000 claims description 17
- 230000004151 fermentation Effects 0.000 claims description 17
- 239000013612 plasmid Substances 0.000 claims description 16
- 238000011144 upstream manufacturing Methods 0.000 claims description 15
- 230000004927 fusion Effects 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 13
- 238000001976 enzyme digestion Methods 0.000 claims description 10
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 9
- 238000012216 screening Methods 0.000 claims description 9
- 239000003550 marker Substances 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 238000011218 seed culture Methods 0.000 claims description 7
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 4
- 239000011230 binding agent Substances 0.000 claims description 4
- 238000006243 chemical reaction Methods 0.000 claims description 4
- 229930027917 kanamycin Natural products 0.000 claims description 4
- 229960000318 kanamycin Drugs 0.000 claims description 4
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 claims description 4
- 229930182823 kanamycin A Natural products 0.000 claims description 4
- 238000012546 transfer Methods 0.000 claims description 4
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 3
- 102000012410 DNA Ligases Human genes 0.000 claims description 3
- 108010061982 DNA Ligases Proteins 0.000 claims description 3
- 241000620209 Escherichia coli DH5[alpha] Species 0.000 claims description 3
- 239000001110 calcium chloride Substances 0.000 claims description 3
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 3
- 238000007857 nested PCR Methods 0.000 claims description 3
- 238000004321 preservation Methods 0.000 claims description 3
- 229920002261 Corn starch Polymers 0.000 claims description 2
- 108090000790 Enzymes Proteins 0.000 claims description 2
- 102000004190 Enzymes Human genes 0.000 claims description 2
- 235000019764 Soybean Meal Nutrition 0.000 claims description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 claims description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 claims description 2
- 235000011130 ammonium sulphate Nutrition 0.000 claims description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 2
- 239000008120 corn starch Substances 0.000 claims description 2
- 238000001514 detection method Methods 0.000 claims description 2
- 238000012163 sequencing technique Methods 0.000 claims description 2
- 239000004455 soybean meal Substances 0.000 claims description 2
- 238000010276 construction Methods 0.000 abstract description 5
- 238000012795 verification Methods 0.000 description 10
- 108020004414 DNA Proteins 0.000 description 8
- 108091023040 Transcription factor Proteins 0.000 description 6
- 102000040945 Transcription factor Human genes 0.000 description 6
- 239000013598 vector Substances 0.000 description 6
- 239000001963 growth medium Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 229940024606 amino acid Drugs 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 108091008146 restriction endonucleases Proteins 0.000 description 3
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 101100510233 Bacillus subtilis (strain 168) kipR gene Proteins 0.000 description 2
- CKLJMWTZIZZHCS-UWTATZPHSA-N D-aspartic acid Chemical compound OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 2
- WHUUTDBJXJRKMK-GSVOUGTGSA-N D-glutamic acid Chemical compound OC(=O)[C@H](N)CCC(O)=O WHUUTDBJXJRKMK-GSVOUGTGSA-N 0.000 description 2
- 229930182847 D-glutamic acid Natural products 0.000 description 2
- COLNVLDHVKWLRT-MRVPVSSYSA-N D-phenylalanine Chemical compound OC(=O)[C@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-MRVPVSSYSA-N 0.000 description 2
- 229930182832 D-phenylalanine Natural products 0.000 description 2
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 229920002097 Lichenin Polymers 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- 238000002944 PCR assay Methods 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000037354 amino acid metabolism Effects 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 239000003674 animal food additive Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 235000021474 generally recognized As safe (food) Nutrition 0.000 description 1
- 235000021473 generally recognized as safe (food ingredients) Nutrition 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 101150028857 phoP gene Proteins 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 239000003910 polypeptide antibiotic agent Substances 0.000 description 1
- 108091008025 regulatory factors Proteins 0.000 description 1
- 102000037983 regulatory factors Human genes 0.000 description 1
- 230000008844 regulatory mechanism Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- QEVHRUUCFGRFIF-MDEJGZGSSA-N reserpine Chemical compound O([C@H]1[C@@H]([C@H]([C@H]2C[C@@H]3C4=C(C5=CC=C(OC)C=C5N4)CCN3C[C@H]2C1)C(=O)OC)OC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 QEVHRUUCFGRFIF-MDEJGZGSSA-N 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000013605 shuttle vector Substances 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 108700026220 vif Genes Proteins 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/75—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/07—Bacillus
- C12R2001/10—Bacillus licheniformis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
The application provides knockoutamtRGene preparation bacitracin engineering bacteria, preparation method and application thereof, wherein the bacitracin engineering bacteria are obtained by knocking out the genome of bacillus licheniformis by adopting genetic engineering meansamtRGene, obtained knockoutamtRPost-gene recombinant strain, saidamtRThe nucleotide sequence of the gene is shown in SEQ ID NO. 1. The application provides a new strategy for improving the yield of bacitracin. And, with Bacillus licheniformis DW2 is the delta of recombinant strain DW2 of Bacillus licheniformis obtained by the construction of the applicationamtRThe yield of bacitracin is improved by more than 18 percent.
Description
Technical Field
The application relates to the fields of genetic engineering and fermentation engineering, in particular to a bacitracin engineering bacterium for knocking out an amtR gene, a preparation method and application thereof.
Background
Bacillus licheniformis is an internationally accepted industrial microorganism strain with biosafety (GRAS), has the advantages of clear genetic background, strong robustness, stable character and the like, and is widely applied to fermentation production of biochemical products such as poly-gamma-glutamic acid, lichenin, phenethyl alcohol, bacitracin and the like.
Bacitracin is a polypeptide antibiotic synthesized by bacillus subtilis and bacillus licheniformis, can strongly inhibit the growth of gram-positive bacteria and partial gram-negative bacteria, has a synergistic enhancement effect when used in combination with other antibiotics, and is thus widely used in the feed additive and veterinary medicine industries. The bacitracin structure includes 11 amino acids of ornithine (Orn), D-phenylalanine (D-Phe), histidine (His), D-aspartic acid (D-Asp), asparagine (Asn), lysine (Lys), D-glutamic acid (D-Glu), cysteine (Cys), leucine (Leu), isoleucine (Ile) and valine (Val). In recent years, strategies concerning high yield of bacitracin have focused mainly on enhancing the supply level of bacitracin precursor amino acids; there are reports of improving bacitracin production by engineering transcription regulatory factors (e.g., phoP, kipR, lrps), however, the mechanism of action of PhoP, kipR, lrps transcription factors in bacteria is not known, and there is no report on the correlation between these transcription factors and transcription factor AmtR (including transcription factors AmtR, genes encoding AmtR, and regulatory subjects of AmtR).
And, the transcription factor AmtR is composed ofamtRThe coding belongs to the TetR family members, and mainly participates in regulating nitrogen metabolic processes in bacteria, including ammonium utilization, urea metabolism, signal transduction and the like. However, the relationship between the ammonium salt utilization efficiency and the amino acid synthesis level is not known, and because of the large variety of bacitracin synthesis precursors, bacitracin amino acid metabolism has a strict and complex regulatory mechanism, and there is no evidence that there is a close relationship between ammonium utilization and amino acid synthesis and bacitracin yield. In addition, there is no report indicating that AmtR is capable of modulating the growth of bacterial cells. Thus, the relationship between the transcription factor AmtR and the bacitracin synthesis level is not clear nor predictable.
Disclosure of Invention
One of the purposes of the present application is to provide a knockoutamtRThe method for preparing the bacitracin engineering bacteria by the genes has stronger capacity of producing bacitracin by fermenting the bacitracin engineering bacteria.
Knocking outamtRA method for preparing bacitracin engineering bacteria by gene adopts genetic engineering means to knock out the bacillus licheniformis genomeamtRGene, obtain knockoutamtRThe recombinant strain after gene (namely the bacitracin-producing engineering bacterium), theamtRThe nucleotide sequence of the gene is shown in SEQ ID NO. 1.
The application adopts a genetic engineering method to knock out the coding gene of the transcription regulatory factor AmtR in the genome of bacillus licheniformisamtRThe gene provides a new strategy for improving the yield of bacitracin.
Preferably, the bacillus licheniformis is bacillus licheniformis DW2 #Bacillus licheniformis DW 2) which has been preserved in China center for type culture collection (China center for type culture collection) in Wuhan at 10 and 12 days 2011, wherein the preservation number is CCTCC NO: M2011344, and Bacillus licheniformis DW2 is an existing strain with high yield of bacitracin, and the bacitracin yield of the obtained recombinant strain is higher by taking the strain as an original strain.
Preferably, the genetic engineering means is used for knocking out the genome of bacillus licheniformisamtRA gene comprising the steps of:
(1) The genome of bacillus licheniformis DW2 is used as a template to be amplified by PCRamtRAn upstream homology arm and a downstream homology arm of the gene;
(2) Connecting the upstream homology arm and the downstream homology arm of the step (1) together by using overlap extension PCR to obtain a homology arm fusion fragment;
(3) By restriction enzymesBamHI andXbai, carrying out double enzyme digestion on the homology arm fusion fragment obtained in the step (2) to obtain an enzyme digestion fusion fragment A; at the same time adoptBamHI andXbai, carrying out double enzyme digestion on plasmid T2 (2) -ori to obtain a linear plasmid fragment after enzyme digestion;
(4) Connecting the enzyme-digested fusion fragment A obtained in the step (3) and the linear plasmid fragment by using T4-DNA ligase, transferring the enzyme-linked product into escherichia coli DH5 alpha by using a calcium chloride conversion method, taking kanamycin as a resistance screening marker, obtaining a positive transformant by colony PCR, and sequencing to obtainamtRKnockout plasmid T2 (2) -ori-amtR;
(5) T2 (2) -ori-amtRTransferring into bacillus licheniformis DW2, and screening by the resistance of kanapigenin to obtain a positive transformant;
(6) The positive transformant which is verified to be correct by colony PCR in the step (5) is subjected to transfer culture for a plurality of times, colony PCR detection is carried out, and screening is carried out to obtainamtRUpstream arm or geneamtRA positive single-crossover binder strain that generates single crossover with bacillus licheniformis DW2 genomic DNA in the downstream arm of the gene;
(7) Subjecting the positive single exchange binder strain obtained in step (6) to several passesCulturing, and screening by combining PCR method to obtain knockoutamtRThe bacillus licheniformis of gene is named: DW2 deltaamtR。
It is a second object of the present application to provide a knockoutamtRA gene-producing bacitracin engineering bacterium which is said knockdown employing one of the objects of the present applicationamtRRecombinant strain constructed by gene preparation method of bacitracin engineering bacteria.
The third purpose of the application is to provide the application of the bacitracin-producing engineering bacteria in bacitracin production, which comprises seed culture and fermentation culture.
In the application, the formula of the fermentation medium used in the fermentation culture is 60-100 g/L soybean meal; 30-50 g/L corn starch; 4-8 g/L calcium carbonate and 0.5-2 g/L ammonium sulfate.
Compared with the prior art, the application has the following technical effects:
the application firstly uses the knocking out in bacillus licheniformisamtRThe gene can increase the yield of bacitracin, and provides a new strategy for bacitracin high yield. Compared with Bacillus licheniformis DW2, the recombinant strain DW2 delta of Bacillus licheniformis constructed by the applicationamtRThe yield of bacitracin is improved by more than 18 percent. The research result of the application shows that: by knocking outamtRGene enhancement of bacitracin production is a very efficient and viable approach.
Drawings
FIG. 1 shows the result of step (1)amtRUpstream homology arm of geneamtRAgarose gel electrophoresis of the downstream homology arm of the gene, wherein lane M is DNA marker, lane 1 isamtRUpstream homology arm of gene, lane 2amtRDownstream homology arms of the gene;
FIG. 2 is an agarose gel electrophoresis of the homology arm fusion fragment obtained in the step (2), wherein lane M is a DNA marker, and lane 1 is a homology arm fusion fragment;
FIG. 3 shows the knockout vector T2 (2) -ori (II) obtained in the step (4)amtRPerforming colony PCR verification, wherein lane M is a DNA marker, and lane 1 is a knockout vector T2 (2) -ori-amtRColony PCR assay was performedA strip of certificates;
FIG. 4 is a colony PCR verification chart of the positive transformant strain obtained in the step (5), wherein lane M is a DNA marker, and lane 1 is a verification band of the positive transformant strain;
FIG. 5 shows the knockdown obtained in step (7)amtRGenetic bacillus licheniformis DW2 deltaamtRWherein lane M is a DNA marker and lane 1 is Bacillus licheniformis DW2 deltaamtRIs a verification strip of (2);
wherein, the molecular weight corresponding to the bands from top to bottom in the DNA marker lanes is as follows: 5000 bp,3000 bp,2000 bp,1500 bp,1000 bp,750bp,500 bp,250 bp,100 bp.
Description of the embodiments
The following examples are further illustrative of the application and are not intended to be limiting thereof. The technical scheme of the application is a conventional scheme in the field if not specifically described; the reagents or materials, unless otherwise specified, are commercially available.
Example 1
Knocking outamtRA method for preparing bacitracin engineering bacteria by gene adopts genetic engineering means to knock out the bacillus licheniformis genomeamtRGene, obtain knockoutamtRThe recombinant strain after gene, namely the bacitracin-producing engineering bacterium, theamtRThe nucleotide sequence of the gene is shown in SEQ ID NO. 1. The bacillus licheniformis is bacillus licheniformis DW2 which is preserved in China Center for Type Culture Collection (CCTCC) in Wuhan in 2011 for 10 months and 12 days, and the preservation number is M2011344. The genetic engineering method is adopted to knock out the genome of the bacillus licheniformisamtRThe specific steps of the gene are as follows:
(1) According to the DW2 genome DNA sequence of bacillus licheniformisamtRGene sequence of gene, designamtRUpstream homology arm primer of geneamtR-F1、amtRR1) and downstream homology arm primeramtR-F2、amtR-R2); and genome DNA of bacillus licheniformis DW2 is used as a template, and respectivelyamtRUpstream homology arm primer and downstream homology arm primer of genePCR amplification of the productamtRUpstream homology arm fragment of geneamtRDownstream homology arm fragments of the gene (as shown in figure 1,amtRthe upstream homology arm fragment of the gene was 582 bp,amtRthe downstream homology arm fragment of the gene is 585 bp);
wherein,amtR-F1、amtR-R1、amtR-F2、amtRthe sequence of R2 is:
amtR-F1:CGGGATCC TTTCTCATCCTTTGACCACG
amtR-R1:CATCAGAAATCCCCCTTTTGATCATCATTCCTTTTC
amtR-F2:GAAAAGGAATGATGATCAAAAGGGGGATTTCTGATG
amtR-R2:GCTCTAGA ATGTAACGGGATCTGCCG
(2) To be used foramtRUpstream homology arm fragment of geneamtRThe downstream homology arm fragment of the gene is used as a template, and the upstream homology arm primeramtRF1, downstream homology arm primeramtRR2 is a primer, and is amplified by overlap extension PCRamtRUpstream homology arm of geneamtRThe downstream homology arms of the genes are connected together to obtain a homology arm fusion fragment (as shown in figure 2, the homology arm fusion fragment is 1247 bp);
(3) By usingXbaI andBamthe HI restriction endonuclease carries out double enzyme digestion on the homology arm fusion fragment in the step (2) to obtain an enzyme digestion fusion fragment;
(4) Plasmid T2 (2) -ori was prepared (wherein plasmid T2 (2) -ori was constructed by amplifying 194-ori from pE194 plasmid, kanamycin resistance gene from pDG780 plasmid, pUC-ori from plasmid pBluescript II SK (+) -X52328 by PCR reaction, and recovering and digestion. Construction of Bacillus subtilis-E.coli multifunctional shuttle vector was carried out according to 194-ori, kanamycin resistance gene, pUC-ori in the order of ligation, reference was made to Guo Xinghua, xiong Zhan et al (1991) [ J ]]Bioengineering report 7 (3) 224-229 and Peng Qingzhong, zhang Weicai et al (2002) construction of Bacillus pumilus-E.coli shuttle secretion expression vector [ J ]]Bioengineering journal 18 (4): 438-441) and usesXbaI andBamHI restriction endonuclease double-cleaves plasmid T2 (2) -oriObtaining a linear plasmid fragment (4250 bp); wherein the restriction enzymeXbaI andBamHI restriction enzymes were purchased from Beijing full gold Biotechnology Co., ltd;
(5) Connecting the enzyme-cleaved gene fragment in the step (3) and the linear plasmid fragment in the step (4) through T4 DNA ligase to obtain a connection product; the ligation product is transferred into escherichia coli DH5 alpha by a calcium chloride transformation method, and is screened by a culture medium containing kanagacillin resistance at 37 ℃ to obtain transformants, and colony PCR verification is carried out on the transformants by using primers T2-F and T2-R (the primers used are T2-F and T2-R). The PCR verification result of the transformant is as follows: the presence of an electrophoretic band at 1535 bp (as shown in fig. 3) indicates successful knockout vector construction, designated: knockout vector T2 (2) -ori-amtR;
Wherein the sequences of T2-F and T2-R are:
T2-F: ATGTGATAACTCGGCGTA、
T2-R: GCAAGCAGCAGATTACGC;
(6) Knockout of vector T2 (2) -ori-amtRThe transformants obtained by the screening were subjected to colony PCR verification by using primers T2-F and T2-R by transferring the transformants into Bacillus licheniformis DW2 by the method of electric shock conversion, screening the transformants by a medium containing kanagacillin resistance at 37 ℃. If the PCR verification result of the transformant is: the appearance of an electrophoretic band at 1535 bp demonstrates that: knockout vector T2 (2) -ori-kipRSuccessfully transferring into bacillus licheniformis DW2, wherein the transformant is a positive transformant;
(7) Transferring the positive transformant obtained in the step (6) to a medium containing kanagamicin resistance at 45 ℃ for 3 times, culturing 12 h each time, and culturing the positive transformant with T2-F andamtRKYR as primer (or T2-R andamtRKYF as primer) to verify single-crossover strains by colony PCR, if the size of the electrophoresis band is 1479 bp or 2094 bp, the single-crossover strains are proved to be successful (as shown in FIG. 4);
wherein the primeramtRKYF andamtRthe sequence of KYR is:
amtR-KYF:GACGCCGTTGTCGGAAGC
amtR-KYR:TGATTTGCGGAGCGGACT
(8) Inoculating the single-exchange strain obtained in the step (7) into a culture medium which does not contain kanapecillin at 37 ℃ for 3-6 times of transfer culture, picking the transformant, and performing colony PCR verification (the primer isamtRKYF andamtRKYR). If the PCR verification result of the transformant is: when an electrophoresis band appears in 1993, bp, it indicates that the gene is back mutated, and the transformant is Bacillus licheniformis DW2; when an electrophoretic band appears at 1378 and bp, it is explained thatamtRThe gene was successfully knocked out in B.licheniformis DW2, a positive transformant (see FIG. 5). The positive transformant is then further sequenced and verified to obtain a knockoutamtRGenetic bacillus licheniformis DW2 deltaamtR。
Next, the present inventors also used the Bacillus licheniformis DW2 delta obtained by the above constructionamtRTo ferment and produce bacitracin. Wherein, bacillus licheniformis DW2 deltaamtRApplications in bacitracin production include seed culture and fermentation culture.
The specific steps of the seed fermentation are as follows: firstly, the bacillus licheniformis DW2 delta is performedamtRThe method comprises the steps of (1% by volume of glycerol tubes are inoculated into 5mL of LB culture medium, the culture is carried out for 12 hours at the temperature of 37 ℃ at 230r/min, then bacterial liquid after bacterial activation is inoculated into seed culture medium at the inoculum size of 1% by volume and then is cultured for 12 hours at the temperature of 37 ℃ at 230r/min, and seed culture liquid is obtained (the formula of the seed culture medium is 10 g/L peptone, 5 g/L yeast extract, 10 g/L sodium chloride and pH 7.2).
The specific steps of the fermentation culture are as follows: and filling 20mL of fermentation culture mediums with different formulas (the specific formulas are shown in table 1, the pH of the fermentation culture mediums used in each example in table 1 is natural, then inoculating the bacterial liquid for seed culture with the inoculation amount of 3% (volume percent), and fermenting and culturing for 48 hours at the temperature of 37 ℃ at the rotating speed of 230r/min to obtain the fermentation liquid.
The present inventors used a High Performance Liquid Chromatography (HPLC) method to determine the yield of bacitracin in the fermented broth produced in the above examples. The measurement conditions are specifically as follows: detecting by using an Agilent 1200 liquid chromatograph; the column was Hypersil BDS C18 (5 μm, 4.6 mm ×250 mm); mobile phase a: b=35:65 (phase a: 100 mL of phosphate buffer solution ph6.0 to 300 mL water, phase B: 520 mL methanol and 40 mL acetonitrile; flow rate: 1.0 mL/min; column temperature 30 ℃; ultraviolet detector wavelength: 254 nm; the sample injection amount was 20. Mu.L. The yield of bacitracin in the fermentation broth was calculated from the standard curve made of bacitracin standard (see table 2).
TABLE 1
TABLE 2
As can be seen from table 2: under the same fermentation conditions, the Bacillus licheniformis DW2 delta is adopted compared with the Bacillus licheniformis DW2 in the prior artamtRThe yield of bacitracin in the fermentation broth is obviously improved (by more than 18 percent), which shows that: the technical scheme of the application has important application value in improving the yield of bacitracin of bacillus licheniformis.
It should be understood by those skilled in the art that the present application may be embodied in many different forms without departing from the spirit or essential characteristics thereof.
Claims (6)
1. Knocking outamtRA method for preparing bacitracin engineering bacteria by gene is characterized in that the gene engineering means is adopted to knock out the genome of bacillus licheniformisamtRGenes and obtain knockoutsamtRThe recombinant strain after gene, namely the bacitracin-producing engineering bacterium, theamtRThe nucleotide sequence of the gene is shown in SEQ ID NO. 1.
2. The knockout of claim 1amtRMethod for preparing bacitracin-producing engineering bacteria by genesIs characterized in that the bacillus licheniformis is bacillus licheniformis DW2 which is preserved in China Center for Type Culture Collection (CCTCC) in Wuhan in 2011 for 10 months and 12 days, and the preservation number is M2011344.
3. The knockout of claim 2amtRThe method for preparing the bacitracin-producing engineering bacteria by genes is characterized in that the genetic engineering means is adopted to knock out the genome of bacillus licheniformisamtRThe gene specifically comprises the following steps:
(1) The genome of bacillus licheniformis DW2 is used as a template to be amplified by PCRamtRAn upstream homology arm and a downstream homology arm of the gene;
(2) Connecting the upstream homology arm and the downstream homology arm of the step (1) together by using overlap extension PCR to obtain a homology arm fusion fragment;
(3) By restriction enzymesBamHI andXbai, carrying out double enzyme digestion on the homology arm fusion fragment obtained in the step (2) to obtain an enzyme digestion fusion fragment A; at the same time adoptBamHI andXbai, carrying out double enzyme digestion on plasmid T2 (2) -ori to obtain a linear plasmid fragment after enzyme digestion;
(4) Connecting the enzyme-digested fusion fragment A obtained in the step (3) and the linear plasmid fragment by using T4-DNA ligase, transferring the enzyme-linked product into escherichia coli DH5 alpha by using a calcium chloride conversion method, taking kanamycin as a resistance screening marker, obtaining a positive transformant by colony PCR, and sequencing to obtainamtRKnockout plasmid T2 (2) -ori-amtR;
(5) T2 (2) -ori-amtRTransferring into bacillus licheniformis DW2, and screening by the resistance of kanapigenin to obtain a positive transformant;
(6) The positive transformant which is verified to be correct by colony PCR in the step (5) is subjected to transfer culture for a plurality of times, colony PCR detection is carried out, and screening is carried out to obtainamtRUpstream arm or geneamtRA positive single-crossover binder strain that generates single crossover with bacillus licheniformis DW2 genomic DNA in the downstream arm of the gene;
(7) The step (6) is carried outThe positive single exchange binder strain of (2) is subjected to transfer culture for several times and is screened by combining a PCR method to obtain knockoutamtRGene Bacillus licheniformis DW2 deltaamtR。
4. Knocking outamtRA gene producing bacitracin engineering bacterium which is obtained by knocking out the gene according to any one of claims 1 to 3amtRRecombinant strain constructed by gene preparation method of bacitracin engineering bacteria.
5. The knockout of claim 4amtRThe application of the gene bacitracin-producing engineering bacteria in bacitracin production comprises seed culture and fermentation culture.
6. The knockout of claim 5amtRThe application of the gene bacitracin-producing engineering bacteria in bacitracin production is characterized in that: the formula of a fermentation medium used for fermentation culture is 60-100 g/L soybean meal; 30-50 g/L corn starch; 4-8 g/L calcium carbonate and 0.5-2 g/L ammonium sulfate.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311128270.6A CN117143900A (en) | 2023-09-04 | 2023-09-04 | Bacillus coagulans engineering bacterium with ambr gene knocked out as well as preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311128270.6A CN117143900A (en) | 2023-09-04 | 2023-09-04 | Bacillus coagulans engineering bacterium with ambr gene knocked out as well as preparation method and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117143900A true CN117143900A (en) | 2023-12-01 |
Family
ID=88885147
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311128270.6A Pending CN117143900A (en) | 2023-09-04 | 2023-09-04 | Bacillus coagulans engineering bacterium with ambr gene knocked out as well as preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117143900A (en) |
-
2023
- 2023-09-04 CN CN202311128270.6A patent/CN117143900A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106978360B (en) | High-yield cellulase trichoderma reesei recombinant strain and application thereof | |
CN107502585A (en) | One plant of bacillus licheniformis engineering bacteria for efficiently synthesizing poly- γ glutamic acid | |
CN112522173B (en) | Engineering bacterium for producing heterologous alkaline protease and construction method thereof | |
KR102246356B1 (en) | Method and application to improve production of Bacillus licheniformis fermentation enzyme through spoⅡQ and pcf gene knockout | |
CN111926013B (en) | Promoter suitable for bacillus licheniformis and application thereof in high-efficiency expression of target product | |
CN107904223A (en) | A kind of algin catenase, the host cell for secreting algin catenase and its application | |
CN108277191B (en) | Application of bacillus licheniformis DW2 delta ccpN in bacitracin production | |
CN108611308B (en) | Preparation method and application of bacillus licheniformis for high-yield poly-gamma-glutamic acid | |
CN111304235B (en) | Bacillus licheniformis for enhancing expression of cysP as well as preparation method and application thereof | |
CN110295189B (en) | Application of 4-aminobutyric acid aminotransferase in improving fermentation yield of iturin A | |
CN109913515B (en) | Method for increasing yield of poly gamma-glutamic acid by improving glycerol metabolism of bacillus | |
CN108588108B (en) | Preparation method and application of bacillus for efficiently metabolizing glycerol | |
CN108018304B (en) | Bacillus licheniformis strain capable of highly producing bacitracin, preparation method and application thereof | |
CN108587996B (en) | Engineering bacterium for high-yield poly-gamma-glutamic acid and construction method and application thereof | |
CN108441508B (en) | Application of bacillus licheniformis DW2 DeltalrPC in bacitracin production | |
CN117143900A (en) | Bacillus coagulans engineering bacterium with ambr gene knocked out as well as preparation method and application thereof | |
CN112359007B (en) | Exogenous introduction edd gene bacillus licheniformis for producing bacitracin and application | |
US20220017886A1 (en) | Linoleic Acid Isomerase and its Application in Production of Conjugated Linoleic Acid | |
CN111549050B (en) | Vitreoscilla hemoglobin expression frame suitable for bacillus and application | |
CN108531438B (en) | Application of bacillus licheniformis DW2 delta bcaP in bacitracin production | |
CN109182240B (en) | Application of bacillus licheniformis DW2 delta phoP in bacitracin production | |
CN112575022A (en) | Construction method of in-vitro artificial scaffold protein-mediated trehalose multienzyme complex | |
CN109868253B (en) | Bacillus licheniformis engineering bacteria for inhibiting bacterial autolysis and construction method and application thereof | |
CN117625510A (en) | Bacitracin engineering bacteria for knocking out oxdC gene and preparation method and application thereof | |
CN110305917B (en) | Application of rex gene of bacillus in improving yield of poly-gamma-glutamic acid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |